Biopharmaceutical Excipient Manufacturing – Current Scenario and Future Trends
Roots Analysis
MARCH 13, 2022
In the last decade alone, the annual number of approvals of biopharmaceuticals (including monoclonal antibodies, recombinant proteins, vaccines and gene therapies), by the US FDA, have steadily risen. For more details on this emerging domain, check out the following report : Exosome Development and Manufacturing Services Market.
52 
Let's personalize your content